News | March 12, 2015

Women Veterans Younger, More Depressed When Referred for Heart Test

Further study needed on stress-induced heart disease, microvascular angina

women veterans, heart disease, test, depression, AHA, VA

March 12, 2015 — Women veterans who had specialized heart tests were younger and more likely to be obese, depressed and suffer from post-traumatic stress disorder than male veterans, according to a study published in an American Heart Association journal.

The number of women cared for by Veteran Affairs facilities has doubled in the past decade, providing a unique opportunity to examine the heart health of women veterans. The study reveals women veterans face a homefront battle against heart disease that's significantly different from men veterans and women who have never served in the military.

Although chest pain was a common reason for women to undergo cardiac catheterization, doctors were less likely to find blockages in women’s arteries that could lead to a heart attack or stroke, said lead study author Melinda B. Davis, M.D., cardiologist at the University of Michigan Frankel Cardiovascular Center and the VA Ann Arbor Healthcare System.

The findings may prompt a closer look at stress-induced heart disease, and coronary microvascular disease —spasms in the walls of very small arterial blood vessels which can lead to severe and long-lasting angina — as causes of chest pain for women veterans.

Additional findings from the national study of nearly 86,000 veterans, including 3,181 women:

  • Generally women are older and have more risk factors for heart disease such as hypertension, diabetes and high cholesterol than men, but women veterans were younger and had fewer heart disease risks than men veterans;
  • Women veterans had higher rates of depression (55.3 percent compared to 31.4 percent) and post-traumatic stress disorder (PTSD, 20 percent compared to 16 percent) than men veterans, highlighting mental health as a potential risk factor for heart disease.
  • Women veterans had similar one-year outcomes after the cardiac catheterization. They were less likely to leave the hospital with heart medications even if doctors found acute disease.

 

The study resulted from the national Veterans Administration Clinical Assessment Reporting and Tracking (CART) program analysis of veterans undergoing cardiac catheterization in the VA system. The median age for women veterans having the heart test was about 57, six years younger than the median age of men veterans.

“Investigating the reasons behind these findings and developing effective approaches based on those insights could potentially help address the gender differences in heart disease we see in the general population,” said senior study author Claire Duvernoy, M.D., chief of cardiology at VA Healthcare Ann Arbor and cardiologist at the U-M Cardiovascular Center.

The VA Ann Arbor and University of Michigan, along with colleagues at the VA Eastern Colorado Health Care System and the University of Colorado School of Medicine, published the study in Circulation: Cardiovascular Quality and Outcomes, an AHA journal. A portion of the March issue is dedicated to research in women.

Women are generally underrepresented in heart disease research, according to the AHA. Because of this gap, physicians lack important information about how women might respond differently to heart disease, have different symptoms and need different diagnostic approaches and treatments.

For more information: www.aha.org

Related Content

HeartSciences Announces CE Mark and European Launch of MyoVista High Sensitivity ECG

Just as a Doppler radar color image shows the energy of a storm, MyoVista provides physicians a detailed visual image of the energy distribution during the cardiac cycle.

News | ECG| August 22, 2017
HeartSciences announced the European launch of the MyoVista high sensitivity electrocardiograph (hsECG) Testing Device...
Medtronic Announces Global Resolute Onyx DES One-Month DAPT Study
News | Antiplatelet and Anticoagulation Therapies| August 18, 2017
Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT...
ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging| August 18, 2017
August 18, 2017 — The American Society of...
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study| August 16, 2017
Aug. 16, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking Clinic
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
Overlay Init